Bronchiectasis Symptoms

bronchiectasis symptoms

Primary Bronchiectasis Symptoms

Bronchiectasis can cause a number of symptoms, the most common of which is a chronic, mucus-producing cough. The mucus can be either clear, yellow or green. In some cases, the mucus can be accompanied by blood.

Additional symptoms of bronchiectasis include:

  • Chronic fatigue
  • Shortness of breath
  • Loud wheezing when inhaling
  • Increased sinus discharge
  • Fevers and/or chills
  • Joint pain

While bronchiectasis symptoms are chronic, many people with the condition experience acute episodes in which their symptoms are more frequent or severe than normal (e.g., the presence of three or more symptoms for at least two consecutive days). These episodes are referred to as exacerbations. Sometimes, exacerbations are accompanied by a lung infection, as bronchiectasis makes people more susceptible to the harmful effects of viruses and bacteria.

Stem cell therapy is an innovative treatment that has become available to individuals who have been diagnosed with bronchiectasis and other lung diseases. This therapy not only has the potential to help reduce inflammation and alleviate symptoms, but it may also help slow the progression of the disease. This makes it an ideal supplement to other traditional forms of treatment. The Lung Institute offers two forms of stem cell therapy, both of which are performed on an outpatient basis over the course of two days. And because the stem cells used in the procedures are taken from the patient’s own body, these treatments are not associated with any major side effects.

If you’d like to learn more about how stem cell therapy might be able to help alleviate your bronchiectasis symptoms, contact the Lung Institute at (800) 729-3065. We have a compassionate team standing by to answer your questions.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.